Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2.

Szczegóły
Abstrakt

Tytuł:: Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2.
Autorzy:: Manna S; Department of Microbiology, Midnapore College (Autonomous), Paschim Medinipur, India.
Baindara P; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, USA.
Mandal SM; Central Research Facility, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. Electronic address: .
Źródło:: Journal of infection and public health [J Infect Public Health] 2020 Oct; Vol. 13 (10), pp. 1397-1404. Date of Electronic Publication: 2020 Jul 14.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: Oxford : Elsevier, 2008-
MeSH Terms:: Bacterial Infections/*immunology
Bacterial Infections/*virology
Coronavirus Infections/*immunology
Influenza, Human/*immunology
Pneumonia, Viral/*immunology
Adaptive Immunity ; Bacteria/growth & development ; Bacterial Adhesion ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Humans ; Immune Tolerance ; Immunity, Innate ; Inflammation/complications ; Influenza, Human/complications ; Microbial Interactions ; Pandemics ; Patient Acuity ; Pneumonia, Viral/complications ; SARS-CoV-2
References:: Lancet Infect Dis. 2020 May;20(5):559-564. (PMID: 32220284)
Allergy. 2020 Jul;75(7):1699-1709. (PMID: 32196678)
Rev Med Virol. 2001 Jul-Aug;11(4):227-41. (PMID: 11479929)
J Immunol. 2014 Apr 1;192(7):3301-7. (PMID: 24563256)
BMC Infect Dis. 2018 Dec 7;18(1):637. (PMID: 30526505)
PLoS One. 2015 May 13;10(5):e0127098. (PMID: 25970287)
Virol J. 2013 Jun 06;10:182. (PMID: 23741982)
J Biol Chem. 2011 Feb 25;286(8):6006-16. (PMID: 21169365)
Nat Rev Immunol. 2017 Jan;17(1):7-20. (PMID: 27890913)
Arch Pathol Lab Med. 2010 Feb;134(2):235-43. (PMID: 20121613)
Pediatr Res. 2005 Dec;58(6):1198-203. (PMID: 16306193)
Ann Glob Health. 2014 Nov-Dec;80(6):476-85. (PMID: 25960097)
JAMA. 2008 Jul 23;300(4):413-22. (PMID: 18647984)
Cell Microbiol. 2009 Sep;11(9):1399-408. (PMID: 19500108)
Curr Opin Immunol. 2015 Jun;34:59-67. (PMID: 25723597)
Emerg Infect Dis. 2008 Aug;14(8):1187-92. (PMID: 18680640)
FEBS Lett. 2002 Dec 4;532(1-2):107-10. (PMID: 12459472)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Mediators Inflamm. 2019 Apr 14;2019:3146065. (PMID: 31097919)
J Clin Invest. 2011 Sep;121(9):3657-65. (PMID: 21841308)
Immunol Rev. 2010 Jul;236:176-89. (PMID: 20636817)
Nat Med. 2020 Apr;26(4):450-452. (PMID: 32284615)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Infect Immun. 1981 May;32(2):941-4. (PMID: 6265368)
Pediatr Res. 2004 Jun;55(6):972-8. (PMID: 15103015)
J Virol. 2006 Feb;80(4):1629-36. (PMID: 16439519)
Clin Infect Dis. 2020 Jul 28;71(15):713-720. (PMID: 32129843)
J Infect Dis. 2003 Oct 1;188(7):1032-9. (PMID: 14513424)
Am J Respir Crit Care Med. 2014 Jul 15;190(2):196-207. (PMID: 24941423)
Nat Rev Immunol. 2017 Feb;17(2):112-129. (PMID: 28028310)
Am J Pathol. 2015 Jun;185(6):1528-36. (PMID: 25747532)
Curr Opin Microbiol. 2013 Apr;16(2):221-7. (PMID: 23597788)
Front Pediatr. 2018 Apr 10;6:96. (PMID: 29692984)
J Immunol. 2013 Aug 1;191(3):1250-9. (PMID: 23804714)
Virology. 2006 Jan 5;344(1):9-16. (PMID: 16364730)
J Dig Dis. 2020 Mar;21(3):125-126. (PMID: 32096611)
Nat Rev Microbiol. 2014 Apr;12(4):252-62. (PMID: 24590244)
N Engl J Med. 2020 Mar 5;382(10):929-936. (PMID: 32004427)
Eur Respir J. 2020 Jul 9;56(1):. (PMID: 32457198)
Viruses. 2020 Feb 22;12(2):. (PMID: 32098422)
Front Microbiol. 2017 Jun 23;8:1041. (PMID: 28690590)
PLoS Pathog. 2012;8(4):e1002616. (PMID: 22496644)
Ther Clin Risk Manag. 2015 Aug 24;11:1265-71. (PMID: 26345407)
J Infect Dis. 1978 Feb;137(2):176-81. (PMID: 627737)
Cell Host Microbe. 2014 Jan 15;15(1):36-46. (PMID: 24439896)
Curr Opin Immunol. 2012 Aug;24(4):417-23. (PMID: 22658762)
FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):189-95. (PMID: 10575129)
Infect Immun. 1981 Apr;32(1):118-26. (PMID: 7216481)
Nature. 1995 Oct 5;377(6548):435-8. (PMID: 7566121)
Antiviral Res. 2014 Oct;110:151-7. (PMID: 25131378)
Cell Microbiol. 2016 Aug;18(8):1043-55. (PMID: 26857242)
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S87-97. (PMID: 14730275)
Crit Care Med. 2012 May;40(5):1487-98. (PMID: 22511131)
J Immunol Res. 2017;2017:8539294. (PMID: 28352642)
Science. 2020 Mar 27;367(6485):1444-1448. (PMID: 32132184)
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. (PMID: 32358954)
Pulmonology. 2020 Jul - Aug;26(4):233-240. (PMID: 32411943)
J Med Microbiol. 2007 Sep;56(Pt 9):1133-1137. (PMID: 17761473)
Cell Mol Immunol. 2014 Mar;11(2):141-9. (PMID: 24509444)
Science. 2019 Nov 1;366(6465):599-606. (PMID: 31672891)
Nat Rev Immunol. 2012 Mar 09;12(4):295-305. (PMID: 22402670)
J Infect Dis. 2003 Mar 15;187(6):1000-9. (PMID: 12660947)
Front Med (Lausanne). 2015 May 11;2:30. (PMID: 26029695)
J Interferon Cytokine Res. 2015 Dec;35(12):925-34. (PMID: 26308503)
PLoS Pathog. 2013 Mar;9(3):e1003238. (PMID: 23555251)
Front Immunol. 2020 Jan 28;11:18. (PMID: 32082311)
Clin Infect Dis. 2004 Aug 15;39(4):511-6. (PMID: 15356814)
Scand J Infect Dis. 2008;40(1):11-7. (PMID: 17852951)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
PLoS Pathog. 2013 Jan;9(1):e1003057. (PMID: 23326226)
MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4. (PMID: 19798021)
J Interferon Cytokine Res. 2015 Apr;35(4):252-64. (PMID: 25714109)
Clin Microbiol Rev. 2006 Jul;19(3):571-82. (PMID: 16847087)
Nat Rev Microbiol. 2018 Feb;16(2):80-90. (PMID: 29109555)
J Virol. 2003 Apr;77(7):4104-12. (PMID: 12634369)
Pediatr Infect Dis J. 2009 Oct;28(10 Suppl):S121-6. (PMID: 19918134)
Infect Immun. 1994 Jul;62(7):2707-14. (PMID: 8005661)
Viral Immunol. 2012 Aug;25(4):277-88. (PMID: 22876772)
Nat Rev Immunol. 2014 May;14(5):315-28. (PMID: 24762827)
J Infect Dis. 2012 Feb 1;205(3):458-65. (PMID: 22158564)
Curr Top Microbiol Immunol. 2014;385:327-56. (PMID: 25027822)
Ann Intensive Care. 2016 Dec;6(1):110. (PMID: 27813024)
Influenza Other Respir Viruses. 2016 Sep;10(5):394-403. (PMID: 27232677)
ANZ J Surg. 2005 Jan-Feb;75(1-2):21-6. (PMID: 15740510)
J Immunol. 2006 Feb 15;176(4):2562-7. (PMID: 16456018)
J Infect Dis. 2011 Mar 15;203(6):880-8. (PMID: 21278211)
J Infect Dis. 2008 Oct 1;198(7):962-70. (PMID: 18710327)
Crit Care. 2010;14(2):219. (PMID: 20459593)
Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773)
PLoS Pathog. 2015 Feb 27;11(2):e1004626. (PMID: 25723501)
Contributed Indexing:: Keywords: Immune response; SARS-CoV-2; Secondary bacterial infection; Viral infection
Entry Date(s):: Date Created: 20200727 Date Completed: 20201013 Latest Revision: 20230306
Update Code:: 20240105
PubMed Central ID:: PMC7359806
DOI:: 10.1016/j.jiph.2020.07.003
PMID:: 32712106
: Czasopismo naukowe

Full Text Finder

Secondary bacterial infections are commonly associated with prior or concomitant respiratory viral infections. Viral infections damage respiratory airways and simultaneously defects both innate and acquired immune response that provides a favorable environment for bacterial growth, adherence, and facilitates invasion into healthy sites of the respiratory tract. Understanding the molecular mechanism of viral-induced secondary bacterial infections will provide us a chance to develop novel and effective therapeutic approaches for disease prevention. The present study describes details about the secondary bacterial infection during viral infections and their immunological changes.The outcome of discussion avails an opportunity to understand possible secondary bacterial infections associated with novel SARS-CoV-2, presently causing pandemic outbreak COVID-19.
(Copyright © 2020. Published by Elsevier Ltd.)

Informacja